BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28356007)

  • 1. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
    Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immortalization of human adipose-derived stromal cells: production of cell lines with high growth rate, mesenchymal marker expression and capability to secrete high levels of angiogenic factors.
    Balducci L; Blasi A; Saldarelli M; Soleti A; Pessina A; Bonomi A; Coccè V; Dossena M; Tosetti V; Ceserani V; Navone SE; Falchetti ML; Parati EA; Alessandri G
    Stem Cell Res Ther; 2014 May; 5(3):63. PubMed ID: 24887516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells.
    Bonomi A; Sordi V; Dugnani E; Ceserani V; Dossena M; Coccè V; Cavicchini L; Ciusani E; Bondiolotti G; Piovani G; Pascucci L; Sisto F; Alessandri G; Piemonti L; Parati E; Pessina A
    Cytotherapy; 2015 Dec; 17(12):1687-95. PubMed ID: 26481416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells uptake and release paclitaxel without reducing its anticancer activity.
    Mariotti M; Colognato R; Rimoldi M; Rizzetto M; Sisto F; Cocce V; Bonomi A; Parati E; Alessandri G; Bagnati R; Pessina A
    Anticancer Agents Med Chem; 2015; 15(3):400-5. PubMed ID: 24942547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
    Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
    Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
    Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
    Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.
    Brini AT; Coccè V; Ferreira LM; Giannasi C; Cossellu G; Giannì AB; Angiero F; Bonomi A; Pascucci L; Falchetti ML; Ciusani E; Bondiolotti G; Sisto F; Alessandri G; Pessina A; Farronato G
    Expert Opin Drug Deliv; 2016 Jun; 13(6):789-98. PubMed ID: 26986001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma.
    Coccè V; Farronato D; Brini AT; Masia C; Giannì AB; Piovani G; Sisto F; Alessandri G; Angiero F; Pessina A
    Sci Rep; 2017 Aug; 7(1):9376. PubMed ID: 28839168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of CC Chemokine Receptor 7 (CCR7) Enables Migration of Xenogeneic Human Adipose-Derived Mesenchymal Stem Cells to Rat Secondary Lymphoid Organs.
    Ma T; Luan SL; Huang H; Sun XK; Yang YM; Zhang H; Han WD; Li H; Han Y
    Med Sci Monit; 2016 Dec; 22():5206-5217. PubMed ID: 28035134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their Secretome.
    Coccè V; Bonomi A; Cavicchini L; Sisto F; Giannì A; Farronato G; Alessandri G; Petrella F; Sordi V; Parati E; Bondiolotti G; Paino F; Pessina A
    Curr Cancer Drug Targets; 2020 Nov; ():. PubMed ID: 33200709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
    Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
    PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immortalized human fetal bone marrow-derived mesenchymal stromal cell expressing suicide gene for anti-tumor therapy in vitro and in vivo.
    Lee WY; Zhang T; Lau CP; Wang CC; Chan KM; Li G
    Cytotherapy; 2013 Dec; 15(12):1484-97. PubMed ID: 24199592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
    Yin N; Yu H; Zhang X; Lv X
    Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody fragment-conjugated gemcitabine and paclitaxel-based liposome for effective therapeutic efficacy in pancreatic cancer.
    Yang W; Hu Q; Xu Y; Liu H; Zhong L
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():328-335. PubMed ID: 29752104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.
    Liu Y; Tamam H; Yeo Y
    AAPS PharmSciTech; 2018 Feb; 19(2):693-699. PubMed ID: 28971370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy.
    Alessandri G; Coccè V; Pastorino F; Paroni R; Dei Cas M; Restelli F; Pollo B; Gatti L; Tremolada C; Berenzi A; Parati E; Brini AT; Bondiolotti G; Ponzoni M; Pessina A
    J Control Release; 2019 May; 302():2-18. PubMed ID: 30890444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.